{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?sponsor=Neothetics%2C+Inc", "query": { "sponsor": "Neothetics, Inc" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 11, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?sponsor=Neothetics%2C+Inc&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-03T04:02:36.862Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01180465", "title": "A Dose-ranging, Study of the Safety and Efficacy of Subcutaneous Injections of LIPO-102 Compared With Placebo for the Reduction of Abdominal Subcutaneous Adiposity", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Weight" ], "interventions": [ { "name": "LIPO-102", "type": "DRUG" }, { "name": "LIPO-102 Low", "type": "DRUG" }, { "name": "LIPO-102, Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neothetics, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 160, "start_date": "2010-04", "completion_date": "2010-09", "has_results": false, "last_update_posted_date": "2015-03-26", "last_synced_at": "2026-09-03T04:02:36.862Z", "location_count": 2, "location_summary": "San Diego, California • New York, New York", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01180465" }, { "nct_id": "NCT01096979", "title": "An Evaluation of the Safety and Efficacy of LIPO-102 for the Reduction of Subcutaneous Abdominal Adiposity", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Subcutaneous Abdominal Adiposity" ], "interventions": [ { "name": "LIPO-102", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neothetics, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 60, "start_date": "2009-10", "completion_date": "2010-03", "has_results": false, "last_update_posted_date": "2015-03-26", "last_synced_at": "2026-09-03T04:02:36.862Z", "location_count": 2, "location_summary": "Anaheim, California • San Diego, California", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01096979" }, { "nct_id": "NCT03005717", "title": "Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fat", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Submental Fat" ], "interventions": [ { "name": "LIPO-202", "type": "DRUG" }, { "name": "Placebo for LIPO-202", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neothetics, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 162, "start_date": "2016-12-22", "completion_date": "2017-06-02", "has_results": false, "last_update_posted_date": "2017-10-20", "last_synced_at": "2026-09-03T04:02:36.862Z", "location_count": 11, "location_summary": "Beverly Hills, California • Manhattan Beach, California • Greenwood Village, Colorado + 8 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Manhattan Beach", "state": "California" }, { "city": "Greenwood Village", "state": "Colorado" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Warren", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03005717" }, { "nct_id": "NCT02397525", "title": "An Open-Label Study to Evaluate Retreatment With LIPO-202", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Central Abdominal Bulging" ], "interventions": [ { "name": "LIPO-202", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neothetics, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": "2015-03", "completion_date": null, "has_results": false, "last_update_posted_date": "2015-08-13", "last_synced_at": "2026-09-03T04:02:36.862Z", "location_count": 8, "location_summary": "Englewood, Colorado • Coral Gables, Florida • Snellville, Georgia + 5 more", "locations": [ { "city": "Englewood", "state": "Colorado" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Snellville", "state": "Georgia" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02397525" }, { "nct_id": "NCT02397499", "title": "Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Central Abdominal Bulging" ], "interventions": [ { "name": "LIPO-202", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neothetics, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 800, "start_date": "2015-04", "completion_date": null, "has_results": false, "last_update_posted_date": "2016-01-08", "last_synced_at": "2026-09-03T04:02:36.862Z", "location_count": 31, "location_summary": "Tucson, Arizona • Hot Springs, Arkansas • Beverly Hills, California + 26 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Fremont", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02397499" }, { "nct_id": "NCT01802723", "title": "Dose Ranging Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Periumbilical Subcutaneous Adipose Tissue Reduction" ], "interventions": [ { "name": "Drug: salmeterol xinafoate", "type": "DRUG" }, { "name": "Drug: Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neothetics, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 472, "start_date": "2013-02", "completion_date": "2013-10", "has_results": false, "last_update_posted_date": "2015-03-26", "last_synced_at": "2026-09-03T04:02:36.862Z", "location_count": 22, "location_summary": "Beverly Hills, California • Encinitas, California • Los Angeles, California + 19 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Encinitas", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Santa Ana", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01802723" }, { "nct_id": "NCT02568319", "title": "Safety and Efficacy Study of LIPO-202 for the Reduction of Central Abdominal Bulging in Obese Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Central Abdominal Bulging" ], "interventions": [ { "name": "LIPO-202", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neothetics, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 120, "start_date": "2015-09", "completion_date": null, "has_results": false, "last_update_posted_date": "2015-12-24", "last_synced_at": "2026-09-03T04:02:36.862Z", "location_count": 6, "location_summary": "Encinitas, California • Manhattan Beach, California • Aventura, Florida + 3 more", "locations": [ { "city": "Encinitas", "state": "California" }, { "city": "Manhattan Beach", "state": "California" }, { "city": "Aventura", "state": "Florida" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT02568319" }, { "nct_id": "NCT01712451", "title": "Dose-ranging Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Abdominal Contour Defects" ], "interventions": [ { "name": "salmeterol xinafoate, fluticasone propionate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "salmeterol xinafoate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neothetics, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 200, "start_date": "2011-08", "completion_date": "2012-10", "has_results": false, "last_update_posted_date": "2015-03-26", "last_synced_at": "2026-09-03T04:02:36.862Z", "location_count": 6, "location_summary": "Beverly Hills, California • San Diego, California • New York, New York + 3 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "New York", "state": "New York" }, { "city": "Raleigh", "state": "North Carolina" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01712451" }, { "nct_id": "NCT00918606", "title": "An Evaluation of the Pharmacokinetics and Safety of LIPO-102 in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Subcutaneous Adipose Tissue Reduction" ], "interventions": [ { "name": "LIPO-102", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neothetics, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 30, "start_date": "2009-02", "completion_date": "2009-06", "has_results": false, "last_update_posted_date": "2015-03-24", "last_synced_at": "2026-09-03T04:02:36.862Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00918606" }, { "nct_id": "NCT02398188", "title": "Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Central Abdominal Bulging" ], "interventions": [ { "name": "LIPO-202", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Evofem Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 793, "start_date": "2015-04-09", "completion_date": "2015-10-29", "has_results": true, "last_update_posted_date": "2019-01-07", "last_synced_at": "2026-09-03T04:02:36.862Z", "location_count": 35, "location_summary": "Birmingham, Alabama • Beverly Hills, California • Encinitas, California + 29 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Encinitas", "state": "California" }, { "city": "Manhattan Beach", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02398188" } ] }